mustophoran 208 mg
cenexi - laboratoires thissen s.a. - belgia - fotemustinum - pulb.+solv. pt. sol. perf. - 208mg - agenti alchilanti nitrozouree
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - carmustina - hodgkin disease; lymphoma, non-hodgkin - agenți antineoplazici - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
carmustina waymade 100 mg
drehm pharma gmbh - austria - carmustinum - pulb.+solv. pt. conc. pt. sol. perf. - 100mg - agenti alchilanti nitrozouree
nobilis nd clone 30, vaccin
intervet international, olanda - virusul - vaccin viu - găini şi curci
cecenu
medac - germania - lomustinum - caps. - 40mg - agenti alchilanti nitrozouree
carmuther 100mg
cn unifarm s.a. - carmustinum - pulb+solv. pt. sol. inj - 100mg - agenti alchilanti nitrozouree
carmustine 100 mg
emcure pharma uk limited - marea britanie - carmustinum - pulb+solv. pt. sol. perf. - 100mg - agenti alchilanti nitrozouree
cecenu 40 mg
medac - germania - lomustinum - caps. - 40mg - agenti alchilanti nitrozouree
peroxid de hidrogen-eladum 30 mg/ml soluţie cutanată
eladum pharma srl - hidrogen peroxydum - soluţie cutanată - 30 mg/ml
peroxid de hidrogen-eladum 30 mg/ml soluţie cutanată
eladum pharma srl - hidrogen peroxydum - soluţie cutanată - 30 mg/ml